| Application no. and date | 13731218.7 (espacenet) (Federated) (European Patent Register), 20130611 | | Patent/reg. no. and date | DK/EP 2861599, 20191218 | | Publication date | 20150422 | | Priority no. and date | US 201261661203 P, 20120618 | | EP pub. no. and date |
EP 2861599 20150422 | | Effective date | | | Applicant/owner | Principia Biopharma Inc., 220 E. Grand Ave.
S. San Francisco, CA 94080, US | | Applicant ref. no. | N404554 | | Inventor | GOLDSTEIN, David Michael, 122 Danbury Lane
Redwood City, California 94061, US,
BERNER, Bret, 4011 54 Ave SW
Seattle
WA 98116, US | | Representative | | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , A61P 37/06 (2006.01) , C07D 487/04 (2006.01) | | Title | REVERSIBLE KOVALENTE PYRROLO- ELLER PYRAZOLOPYRIMIDINER, DER ER NYTTIGE TIL BEHANDLING AF CANCER OG AUTOIMMUNSYGDOMME | | Int. application no. | US2013045266 | | Int. publication no. | WO2013191965 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
